VivoSeq
Other

MMR Vaccine

0

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

MMR Vaccine is an early-stage landscape with 0 programs across 1 company. The most active players are GSK.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

GSK logo

GSK

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

5

clinical trials

Completed4 · 80%
Not yet recruiting1 · 20%

Clinical Trials

Trial Activity

A Comparative Study to Assess Efficacy of Intralesional MMR Vaccine and Intralesional Vitamin D3 in Treatment of Warts
Completed·—·N/A·NCT04428359·66 enrolled
Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.
Completed·GSK logoGSK·Phase 4·NCT00388440·150 enrolled
Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months
Completed·SShanghai Institute Of Biological Products·Phase 3·NCT06399003·1,200 enrolled
Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine
Not yet recruiting·SSinovac (Dalian) Vaccine Technology Co., Ltd.·Phase 4·NCT06891872·720 enrolled
Non-specific Effects of FLU-MMR Vaccines in Adults
Completed·RRadboud University Medical Center·Phase 1·NCT05401448·638 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)